ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
Open Access
Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention
Event:
ESC CONGRESS 2017
Topic:
Atrial fibrillation (AF)
Session type:
Satellite Symposium
Sponsored by Bayer AG
Date:
28 August 2017
Time:
12:45 - 13:45
Session
0
5
presentations
in this session
Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.
Speaker:
Professor R. Mehran (New York, US)
Access
Slides
Video
0
New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.
Speaker:
Professor K. Fox (Edinburgh, GB)
Access
Slides
Video
0
Special considerations in the management of patients with AF undergoing ablation or cardioversion.
Speaker:
Professor S. Hohnloser (Frankfurt, DE)
Access
Slides
Video
0
How can we appropriately treat multimorbid patients with AF?
Speaker:
Doctor C. Ruff (Boston, US)
Access
Slides
Video
0
Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.
Speaker:
Doctor R. Cappato (Milan, IT)
Access
Slides
Video
0
5
speakers
from this session
Professor Roxana Mehran
Icahn School of Medicine at Mount Sinai, New York (United States of America)
28
presentations
1
follower
Professor Keith Fox
University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
35
presentations
0
follower
Professor Stefan H Hohnloser
Johann Wolfgang Goethe University, Frankfurt (Germany)
27
presentations
1
follower
Doctor Christian Ruff
Brigham and Women's Hospital, Boston (United States of America)
20
presentations
0
follower
Doctor Riccardo Cappato
Humanitas Research Hospital, Milan (Italy)
12
presentations
0
follower
This platform is supported by